| Aerosol-generating interventions (AGI) for conditions during the COVID-19 pandemic period
|
SESLHDPR/754 |
|
| Clinical Pathway Guideline
|
SESLHDGL/037 |
|
| Continuous Positive Airway Pressure (CPAP) and Non Invasive Ventilation (NIV) Domiciliary Device use by Inpatients with previously diagnosed obstructive sleep apnoea/sleep related breathing disorder
|
SESLHDPR/434 |
|
Heparin - Anticoagulation with Intravenous Heparin Sodium Infusion
|
SESLHDPR/402 |
|
| Heparin Induced Thrombocytopaenia - Diagnosis and Management
|
SESLHDGL/123 |
|
| Intra-Pleural Fibrinolysis - Medical Management of Empyema
|
SESLHDPR/631 |
|
| Management of the Deteriorating ADULT inpatient (excluding maternity)
|
SESLHDPR/697 |
|
| Medicine: Frusemide use in Adult Chronic Heart Failure Patients
|
SESLHDPD/169 |
|
| Pentamidine Aerosolised Therapy in Adults
|
SESLHDPR/696 |
|
| Reducing Cardiothoracic Surgical Site Infections through use of a Cardiothoracic Surgical Site Infection Care Bundle Guideline
|
SESLHDGL/066 |
|
| Respiratory Equipment – Cleaning and Decontamination
|
SESLHDPR/738 |
|
| Sedation: Procedural Sedation (Adults, Ward, Clinic and Imaging areas)
|
SESLHDPR/528 |
|
| Tracheostomy Clinical Management Procedures for Adult Inpatients
|
SESLHDPR/298 |
|
